姑息治疗咨询 (PCC) 已被证明可以改善生活质量并降低各种危及生命的慢性疾病的费用。尽管 PCC 已纳入现代胰腺癌护理指南，但有关其具体利用和对资源使用影响的数据有限。2016-2020 年全国再入院数据库用于确定所有因胰腺癌住院的成人。仅纳入 90 天内至少有 1 次再入院的患者，以解释未记录的院外死亡率。使用多变量回归模型来确定住院 PCC 初次住院期间与指数以及累积费用、总住院时间 (LOS)、再入院率和重复住院次数之间的关系。在估计的 175,805 名胰腺癌患者中，11.1 % 在指数入院期间患有住院 PCC。 PCC 利用率从 2016 年的 10.5% 显着增加到 2020 年的 11.6% (nptrend < 0.001)。调整后，PCC 与住院费用指数降低相关[β：- $1100； 95%置信区间（CI）- 1500，- 800； P < 0.001] 和累计 90 天成本（β：- $11,700；95% CI - 12,700，- 10,000；P < 0.001）。 PCC 与更长的 LOS 指数相关（β： 1.12 天，95% CI 0.92-1.31，P < 0.001），但累积 LOS 显着降低（β：- 3.16 天；95% CI - 3.67，- 2.65；P < 0.001）。最后，PCC 与 30 天非选择性再入院几率降低相关（AOR：0.48，95% CI 0.45-0.50，P < 0.001）。PCC 与胰腺癌患者的费用、再入院率和住院次数降低相关。应实施提高利用率和减少咨询障碍的定向策略，以鼓励从业人员最大限度地提高住院 PCC 转诊率。© 2023。外科肿瘤学会。

Palliative care consultation (PCC) has been shown to improve quality of life and reduce costs for various chronic life-threatening diseases. Despite PCC incorporation into modern pancreatic cancer care guidelines, limited data regarding its specific utilization and impact on resource use is available.The 2016-2020 Nationwide Readmissions Database was used to identify all adult hospitalizations entailing pancreatic cancer. Only patients with at least one readmission within 90 days were included to account for uncaptured out-of-hospital mortality. Multivariable regression models were used to ascertain the relationship between inpatient PCC during initial hospitalization and index as well as cumulative costs, overall length of stay (LOS), readmission rate, and number of repeat hospitalizations.Of an estimated 175,805 patients with pancreatic cancer, 11.1% had inpatient PCC during the index admission. PCC utilization significantly increased from 10.5% in 2016 to 11.6% in 2020 (nptrend < 0.001). After adjustment, PCC was associated with reduced index hospitalization costs [β: - $1100; 95% confidence interval (CI) - 1500, - 800; P < 0.001] and cumulative 90-day costs (β: - $11,700; 95% CI - 12,700, - 10,000; P < 0.001). PCC was associated with longer index LOS (β: + 1.12 days, 95% CI 0.92-1.31, P < 0.001) but significantly reduced cumulative LOS (β: - 3.16 days; 95% CI - 3.67, - 2.65; P < 0.001). Finally, PCC was linked with decreased odds of 30-day nonelective readmission (AOR: 0.48, 95% CI 0.45-0.50, P < 0.001).PCC was associated with decreased costs, readmission rates, and number of hospitalizations among patients with pancreatic cancer. Directed strategies to increase utilization and reduce barriers to consultation should be implemented to encourage practitioners to maximize inpatient PCC referral rates.© 2023. Society of Surgical Oncology.